Ngā hua rapu - Dong‐Hyeon Kim
- E whakaatu ana i te 1 - 12 hua o te 12
-
1
-
2
-
3
4-1BB Engagement Costimulates NKT Cell Activation and Exacerbates NKT Cell Ligand-Induced Airway Hyperresponsiveness and Inflammation mā Dong‐Hyeon Kim, Woo‐Sung Chang, Yoon Sook Lee, Kyoo‐A Lee, Yoon‐Keun Kim, Byoung S. Kwon, Chang‐Yuil Kang
I whakaputaina 2008Artigo -
4
-
5
Subcutaneous Infliximab Monotherapy Versus Combination Therapy with Immunosuppressants in Inflammatory Bowel Disease: A Post Hoc Analysis of a Randomised Clinical Trial mā Geert D’Haens, Walter Reinisch, Stefan Schreiber, Fraser Cummings, Peter M. Irving, Byong Duk Ye, Dong‐Hyeon Kim, Sang-Wook Yoon, Shomron Ben–Horin
I whakaputaina 2023Artigo -
6
Fate of Escherichia coli O157:H7 and bacterial diversity in corn silage contaminated with the pathogen and treated with chemical or microbial additives mā Ibukun M Ogunade, Yun Jiang, Dong Hyeon Kim, Andres A Pech-Cervantes, K.G. Arriola, D. Vyas, Z.G. Weinberg, Kwangcheol Casey Jeong, A.T. Adesogan
I whakaputaina 2016Artigo -
7
Exogenous fibrolytic enzymes and recombinant bacterial expansins synergistically improve hydrolysis and in vitro digestibility of bermudagrass haylage mā Andres A Pech-Cervantes, Muhammad Ishaq, Ibukun M Ogunade, Yun Jiang, Dong Hyeon Kim, Claudio F. González, Timothy J. Hackmann, André Soares de Oliveira, D. Vyas, A.T. Adesogan
I whakaputaina 2019Artigo -
8
Dynamic Changes in Fecal Microbial Communities of Neonatal Dairy Calves by Aging and Diarrhea mā Eun Tae Kim, Sang-Jin Lee, Tae-Yong Kim, Hyo Gun Lee, Md Atikur Rahman, Bon‐Hee Gu, Dong Hyeon Kim, Beom-Young Park, Jun-Kyu Son, Myunghoo Kim
I whakaputaina 2021Artigo -
9
Comparative Efficacy of Subcutaneous and Intravenous Infliximab and Vedolizumab for Maintenance Treatment of TNF-naive Adult Patients with Inflammatory Bowel Disease: A Systematic... mā Laurent Peyrin–Biroulet, Peter Bossuyt, Dominik Bettenworth, Edward V. Loftus, Suzanne I. Anjie, Geert D’Haens, Masayuki Saruta, Perttu Arkkila, Henry S. Park, Dughyun Choi, Dong‐Hyeon Kim, Walter Reinisch
I whakaputaina 2024Revisão -
10
Comparative efficacy and safety of infliximab and vedolizumab therapy in patients with inflammatory bowel disease: a systematic review and meta-analysis mā Laurent Peyrin–Biroulet, Perttu Arkkila, Alessandro Armuzzi, Silvio Danese, Jordi Guardiola, Jørgen Jahnsen, Charlie W. Lees, Édouard Louis, Milan Lukáš, Walter Reinisch, Xavier Roblin, Minyoung Jang, Han Geul Byun, Dong‐Hyeon Kim, Sung Jeong Lee, Raja Atreya
I whakaputaina 2022Revisão -
11
Development and Validation of a Deep Learning–based Automatic Detection Algorithm for Active Pulmonary Tuberculosis on Chest Radiographs mā Eui Jin Hwang, Sunggyun Park, Kwang-Nam Jin, Jung Im Kim, So Young Choi, Jong Hyuk Lee, Jin Mo Goo, Jaehong Aum, Jae‐Joon Yim, Chang Min Park, Dong Hyeon Kim, Woo Woo, Choi Choi, Inpyeong Hwang, Yong Sub Song, Lim Lim, Kim Kim, Jae Yeon Wi, S. Oh, Mi‐Jin Kang
I whakaputaina 2018Artigo -
12
Targeting FLT3-TAZ signaling to suppress drug resistance in blast phase chronic myeloid leukemia mā Ji Eun Shin, Soo‐Hyun Kim, Mingyu Kong, Hwa-Ryeon Kim, Sungmin Yoon, Kyung‐Mi Kee, Jung Ah Kim, Dong Hyeon Kim, So Yeon Park, Jae Hyung Park, Hongtae Kim, Kyoung Tai No, Han‐Woong Lee, Heon Yung Gee, Seunghee Hong, Kun‐Liang Guan, Jae‐Seok Roe, Hyunbeom Lee, Dong‐Wook Kim, Hyun Woo Park
I whakaputaina 2023Artigo
Ngā utauta rapu:
Ngā marau whai pānga
Biology
Medicine
Genetics
Internal medicine
Bacteria
Biochemistry
Food science
Microbiology
Chemistry
Disease
Gastroenterology
Immunology
Infliximab
Lactobacillus
Ulcerative colitis
16S ribosomal RNA
Bacteroidetes
Chromatography
Clinical trial
Dry matter
Ecology
Feces
Fermentation
Gene
Inflammatory bowel disease
Lactic acid
Organic chemistry
Pathology
Randomized controlled trial
Vedolizumab